Patients


Take Control of Your Healing Process

Get back on track with our innovative treatments & accurately targeting the source of pain.

Therapies That Engage and Enhance the Body’s Natural Healing Process

Active Healing Therapies

At Bioventus, our Active Healing Therapies trigger the body’s natural healing process to help patients suffering from either fractures or osteoarthritic joint pain get back to their best selves.  These products are known for their innovation, safety and effectiveness. Our Active Healing Therapies empower patients to take control of their own healing process, and helps get patients back to their normal day-to-day lives.

SURGICAL

Bioventus Surgical is driven to advance the science and surgical performance of orthobiologics with a comprehensive portfolio of clinically efficacious and cost effective solutions. Bioventus Surgical also believes in evidence based medicine and we have several ongoing clinical studies spread across many of our offerings.

For patients outside of the US, please review the Use of Personal Information Terms.

Effective Therapies

Safe, Innovative and Effective Orthopaedic Therapies

Our treatment alternatives may help keep patients out of the hospital, providing therapies that are easily administered either at the patient’s home or in the doctor’s office to stimulate the body’s natural healing process.

What is Active Healing

When a cast is placed on a broken leg, it is not the cast itself that heals the bone; it is the human body itself that works overtime to fix what’s broken. Many therapies for bone health rely on this sort of passive healing, where one must wait for the human body to repair itself.

At Bioventus, we have a different approach to bone health that doesn’t involve drugs or surgery. We call this approach “active healing.” Our products work with the body, enhancing the body’s natural healing processes. Our innovative products – rooted in biology – accelerate recovery by reducing the need for costly, more invasive procedures.

Faster Fracture Healing with EXOGEN

Patients who are recovering from fractures are increasingly turning to EXOGEN to aid their healing process. EXOGEN is the only FDA approved bone growth stimulator that uses ultrasound waves to activate cells near the site of the break. EXOGEN is particularly useful in healing non-union bone fractures that might otherwise require surgery to heal. EXOGEN only requires 20 minutes a day of use, and has been clinically proven to heal 86% of non-union bone fractures1. EXOGEN can also speed the healing of an indicated* broken tibia or radius by 38% – this could shorten recovery time by weeks 2,3.

For more information including full prescribing information and clinical research, visit the EXOGEN website.

BONES Studies Information

Announced in March of 2017, Bioventus has commissioned an innovative series of clinical studies to further validate the ability of the EXOGEN® Ultrasound Bone Healing System to mitigate the risk of a fracture progressing to nonunion in the presence of known risk factors. Learn more

Joint Therapies That Ease Pain and Increase Mobility

When osteoarthritis strikes at joints, it depletes the body’s natural lubrication, which can cause so much pain and discomfort that sometimes the entire joint is replaced surgically. Bioventus offers effective joint therapies that:

  • Attacks the pain directly in the joints
  • Provides pain relief that can last for months
  • Re-lubricates the joints for increased mobility
  • Improves cartilage integrity that further reduces joint pain

Discover how our joint therapies are the solution osteoarthritis patients need.

Learn more about GELSYN-3 , SUPARTZ FX , and DUROLANE .

Our mission is to provide excellent orthopaedic care to patients worldwide. To this end, we want to provide patients with accessible information on our treatments and products.

Supartz FX logo
Visit Website

Available in the US only.

Gelsyn-3 logo
Visit Website

Available in the US only.

  1. Nolte PA, van der Krans A, Patka P, Janssen IM, Ryaby JP, Albers GH. Low-intensity pulsed ultrasound in the treatment of nonunions. J Trauma. 2001;51(4):693-703.
  2. Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF. Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg Am. 1994;76(1):26-34.
  3. Kristiansen TK, Ryaby JP, McCabe J, Frey JJ, Roe LR. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound. A multicenter, prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 1997;79(7):961-73.

*EXOGEN Summary of Indications for Use: The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established non-unions† excluding skull and vertebra. In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopaedically managed by closed reduction and cast immobilization.

There are no known contraindications for the EXOGEN device. Safety and effectiveness has not been established for individuals lacking skeletal maturity; pregnant or nursing women; patients with cardiac pacemakers; on fractures due to bone cancer; or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. Full prescribing information can be found in product labeling, at www.exogen.com or by contacting customer service at 1-800-396-4325.

†A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing.

GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g. acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found in product labeling, at www.GELSYN3.com/PIor by contacting customer service at 1-800-836-4080.

SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women or children. Risks can include general knee pain, warmth and redness at the injection site. Full prescribing information can be found in product labeling, at www.SUPARTXFX.com or by contacting customer service at 1-800-396-4325.

DUROLANE indications vary by market, but include the following: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in the EU for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, toes and temporomandibular and facet joints. DUROLANE is also indicated for pain following joint arthroscopy either in the presence of osteoarthritis or subsequent to general surgical repair within 3 months of the procedure.

There are no known contraindications. You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/or stiffness at the injection site. Full prescribing information can be found in product labeling, at www.durolane.com or by contacting customer service at 1-800-396-4325.